Point72 Asset Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-569,146
| Closed | -$88.7M | – | 1315 |
|
|
2025
Q1 | $88.7M | Buy |
569,146
+65,477
| +13% | +$10.2M | 0.2% | 106 |
|
|
2024
Q4 | $69.3M | Buy |
503,669
+8,122
| +2% | +$1.12M | 0.15% | 144 |
|
|
2024
Q3 | $74M | Buy |
+495,547
| New | +$74M | 0.19% | 122 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1765 |
|
|
2023
Q2 | – | Sell |
-771,110
| Closed | -$82.7M | – | 1628 |
|
|
2023
Q1 | $82.7M | Buy |
771,110
+396,400
| +106% | +$42.5M | 0.26% | 87 |
|
|
2022
Q4 | $45.8M | Sell |
374,710
-9,490
| -2% | -$1.16M | 0.16% | 162 |
|
|
2022
Q3 | $39.7M | Buy |
+384,200
| New | +$39.7M | 0.16% | 160 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1045 |
|
|
2022
Q1 | – | Sell |
-112,200
| Closed | -$15.1M | – | 1057 |
|
|
2021
Q4 | $15.1M | Buy |
112,200
+19,891
| +22% | +$2.68M | 0.06% | 382 |
|
|
2021
Q3 | $14.7M | Buy |
92,309
+7,209
| +8% | +$1.15M | 0.06% | 371 |
|
|
2021
Q2 | $11.2M | Buy |
85,100
+50,100
| +143% | +$6.59M | 0.05% | 398 |
|
|
2021
Q1 | $4.51M | Sell |
35,000
-6,700
| -16% | -$864K | 0.02% | 557 |
|
|
2020
Q4 | $6.96M | Buy |
+41,700
| New | +$6.96M | 0.03% | 499 |
|
|
2020
Q2 | – | Sell |
-72,600
| Closed | -$8.18M | – | 759 |
|
|
2020
Q1 | $8.18M | Buy |
+72,600
| New | +$8.18M | 0.07% | 310 |
|